Increased stiffness of the tumor microenvironment in colon cancer stimulates cancer associated fibroblast-mediated prometastatic activin A signaling.
Jessica BauerMd Abul Bashar EmonJonas Jaromir StaudacherAlexandra L ThomasJasmin Zessner-SpitzenbergGeorgina MancinelliNancy KrettM Taher SaifBarbara JungPublished in: Scientific reports (2020)
Colorectal cancer (CRC) is the second deadliest cancer in the US due to its propensity to metastasize. Stromal cells and especially cancer-associated fibroblasts (CAF) play a critical biophysical role in cancer progression, but the precise pro-metastatic mechanisms are not clear. Activin A, a TGF-β family member, is a strong pro-metastatic cytokine in the context of CRC. Here, we assessed the link between biophysical forces and pro-metastatic signaling by testing the hypothesis that CAF-generated mechanical forces lead to activin A release and associated downstream effects. Consistent with our hypothesis, we first determined that stromal activin A secretion increased with increasing substrate stiffness. Then we found that stromally-secreted activin A induced ligand-dependent CRC epithelial cell migration and epithelial to mesenchymal transition (EMT). In addition, serum activin A levels are significantly increased in metastatic (stage IV) CRC patients (1.558 ng/ml versus 0.4179 ng/ml, p < 0.05). We propose that increased tumor microenvironment stiffness leads to stromal cell-mediated TGF-β family signaling relying on the induction and utilization of activin A signaling.
Keyphrases
- squamous cell carcinoma
- small cell lung cancer
- cell migration
- papillary thyroid
- bone marrow
- transforming growth factor
- ejection fraction
- end stage renal disease
- anti inflammatory
- squamous cell
- epithelial mesenchymal transition
- single cell
- stem cells
- cell therapy
- prognostic factors
- endothelial cells
- drug induced
- lymph node metastasis
- structural basis